The Offering was conducted on a firm commitment basis. AC Sunshine Securities LLC acted as the underwriter for the Offering ...

including Fluorescent Immunochromatographic Solution (FIA), Chemiluminescent Immunoassay Solution (ChLIA), Polymerase Chain Reaction Solution (PCR), Lateral Flow Assay Solution (LFIA), and Loop ...

The Company expects to receive aggregate gross proceeds of US$8 million from the Offering, before deducting underwriting discounts and other related expenses. The Offering is expected to close on or ...

Morningstar brands and products Company Portfolio ...

The firm plans to use the proceeds to support its commercialization and R&D activities as well as for working capital and general corporate purposes.

By targeting surface markers on cancer cells, engineered synthetic receptors expressed on immune cells can be directed to ...